# Stability of Dexamethasone during Hot-Melt Extrusion of Filaments based on Eudragit® RS, Ethyl Cellulose and Polyethylene Oxide

**Authors:** Vanessa Domsta, Tessa Boralewski, Martin Ulbricht, Philipp Schick, Julius Krause, Anne Seidlitz

PMC · DOI: 10.1016/j.ijpx.2024.100263 · International Journal of Pharmaceutics: X · 2024-06-21

## TL;DR

This study examines how processing conditions affect the stability of dexamethasone during hot-melt extrusion, a method for drug delivery implants.

## Contribution

The study identifies optimal extrusion parameters for preserving dexamethasone stability and highlights the importance of analytical methods in drug processing.

## Key findings

- Processing temperature had the strongest impact on dexamethasone stability, reducing recovery to below 20% under certain conditions.
- Differences in drug stability were observed between tested polymers, but additives had minimal effect.
- Suitable extrusion parameters were identified to achieve high dexamethasone recovery rates.

## Abstract

Hot-melt extrusion (HME) potentially coupled with 3D printing is a promising technique for the manufacturing of dosage forms such as drug-eluting implants which might even be individually adapted to patient-specific anatomy. However, these manufacturing methods involve the risk of thermal degradation of incorporated drugs during processing. In this work, the stability of the anti-inflammatory drug dexamethasone (DEX) was studied during HME using the polymers Eudragit® RS, ethyl cellulose and polyethylene oxide. The extrusion process was performed at different temperatures. Furthermore, the influence of accelerated screw speed, the addition of the plasticizers triethyl citrate and polyethylene glycol 6000 or the addition of the antioxidants butylated hydroxytoluene and tocopherol in two concentrations were studied. The DEX recovery was analyzed by a high performance liquid chromatography method suitable for the detection of thermal degradation products. The strongest impact on the drug stability was found for the processing temperature, which was found to reduce the DEX recovery to <20% for certain processing conditions. In addition, differences between tested polymers were observed, whereas the use of additives did not result in remarkable changes in drug stability. In conclusion, suitable extrusion parameters were identified for the processing of DEX with high drug recovery rates for the tested polymers. Moreover, the importance of a suitable analysis method for drug stability during HME that is influenced by several parameters was highlighted.

Unlabelled Image

## Linked entities

- **Chemicals:** dexamethasone (PubChem CID 5743), triethyl citrate (PubChem CID 6506), polyethylene glycol 6000 (PubChem CID 174), tocopherol (PubChem CID 14986)

## Full-text entities

- **Diseases:** inflammatory (MESH:D007249)
- **Chemicals:** Ethyl Cellulose (MESH:C013517), Polyethylene Oxide (MESH:D011092), Eudragit  RS (MESH:C050528), polyethylene glycol 6000 (MESH:C000595215), butylated hydroxytoluene (MESH:D002084), DEX (MESH:D003907), tocopherol (MESH:D024505), polymers (MESH:D011108), triethyl citrate (MESH:C023001)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11260382/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11260382/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC11260382/full.md

---
Source: https://tomesphere.com/paper/PMC11260382